|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Outcomes of partial splenic embolization in patients with massive splenomegaly due to idiopathic portal hypertension显示文摘AIM To determine the outcomes of partial splenic em-bolization(PSE) for massive splenomegaly due to idiopathic portal hypertension(IPH).METHODS In this prospective study, we evaluated the charac-teristics and prognosis of consecutive patients with IPH who underwent PSE for all indications at a single medical center between June 2009 and January 2015. The inclusion criteria were: presence of hypersplenism, massive splenomegaly, and resultant pancytopenia. The exclusion criteria were: presence of other diseases causing portal hypertension. During the post-PSE period, the patients were hospitalized. All patients underwent abdominal computed tomography imaging 4 wk post-PSE to determine total splenic and non-infarcted splenic volumes.RESULTS A total of 11 patients, with median age of 33.27 ± 4.8 years, were included in the study. Mean spleen size was 22.9 cm(21-28 cm), and severe hypersplenismwas diagnosed in all patients before PSE. Post-PSE, leukocyte and platelet counts increased significantly, reaching peak levels in the second week with gradual decreases thereafter. Liver function tests did not exhibit significant changes during post-intervention follow-up. All patients developed post-embolization syndrome, and one patient experienced serious complications; all complications were successfully treated with conservative therapy and no death occurred. CONCLUSION Our findings showed that PSE has a lower complication rate than previously-reported surgical complication rates, which supports this intervention as a viable alternative for high-risk operable patients with severe hypersplenism. | Omer Ozturk Gonca Eldem Bora Peynircioglu Taylan Kav Aysegul Gormez Barbaros Erhan Cil Ferhun Balkanci Cenk Sokmensuer Yusuf Bayraktar | 2016 | World Journal of Gastroenterology2016，22，43： | 18 |
| 2 | Does endothelium agree with the concept of idiopathic hepatic vessel thrombosis?显示文摘瞄准:为了调查血栓形成的主要的步并且在这些识别差别,走在自发的耐心的组和控制组之间。方法:Fibrinogenesis 被测量激活的第七因子,总数和织物因素小径禁止者(TFPI ) 的免费层次学习。纤维蛋白溶解作用步被决定全球 fibrinolytic 能力调查。内皮功能被测量可溶的粘附分子的层次估计,也就是可溶的细胞间的粘附分子 1 (sICAM-1 ) ,可溶的脉管的房间粘附分子 1 (sVCAM-1 ) 并且可溶的 E-selectin 分子。从“自发”的耐心的组的排除标准是腹的外科,怀孕,口服避孕药的使用, anti-phospholipid 症候群, Behcet 的疾病,癌症, myeloproliferative 疾病。先天的因素喜欢 factor-V Leiden 的变化,凝血素,蛋白质 C 和 S 的缺乏,反凝血酵素, hyperhomocysteinemia 和 hyperfibrinogenemia 被排除。病人的全部的数字从 96 ~ 9 被减少(7 与门静脉血栓, 2 Budd Chiari 症候群) 由排除标准。结果:粘附分子 sICAM-1, sVCAM-1,免费 TFPI 层次和全球 fibrinolytic 能力的层次是显著地不同的(P<0.05 ) 在耐心的组显示一个内皮机能障碍和一项更低的 fibrinolytic 活动。结论:这些结果证明这个耐心的组应该借助于内皮机能障碍被测试并且不同地设法。 | Ozgur Harmanci Yahya Buyukasik Serafettin Kirazli Ferhun Balkanci Yusuf Bayraktar | 2006 | World Journal of Gastroenterology2006，12，8： | 4 |
| 3 | Is portal hypertension due to liver cirrhosis a major factor in the development of portal hypertensive gastropathy显示文摘 | Bayraktar Y Balkanci F Uzunalimoglu B | 1996 | Am J Gastroenterol1996，91，6： | 1 |
| 4 | Is Portal hy pertension due to liver cinhosis a maion factor in the develop ment of portal hypertensive gastropahty显示文摘 | Bayraktar Y Balkanci F Uzunalimoglu B | 1996 | Am J Gastroen terol1996，91，： | 1 |
| 5 | The 'pseudo-cholangiocarcinoma sign' in patients with cavernous transformation of the portal vein and its effect on the serum alkaline phosphatase and bilirubin levels显示文摘 | Bayraktar Y Balkanci F Ozenc A | 1995 | Am J Gastroenterol1995，90，11： | 1 |
| 6 | Bile duct varices or 'pseudo-cholangiocarcinoma sign'in portal hypertension due to cavernous transformation of the portal vein 显示文摘 | Bayraktar Y Balkanci F Kayhan B | 1992 | Am J Gastroenterol1992，87，2： | 1 |
| 7 | The 'pseudo-cholangiocarcinoma sign' in patients with cavernous transformation of the portal vein and its effect on the serum alkaline phosphatase and bilirubin levels显示文摘 | Bayraktar Y Balkanci F Ozenc A Arslan S Koseoglu T Ozdemir A | 1995 | Am J Gastroenterol1995，90，11： | 1 |
| 8 | Is portal hypertensionduo to liver cirrhosis a major factor in the development of portal hypertensive gastropathy AM显示文摘 | Bayraktar Y Balkanci F Uzunali moglu B | 1996 | Gastroenterol1996，91，： | 1 |
| 9 | Is portal hypertension due to liver cirrhosis a major factor in the development of portal hypertensive gastropathy?显示文摘 | Bayraktar Y Balkanci F Uzunalimoglu B | 1996 | Am J Gastroenterol1996，91，3： | 1 |
| 10 | Bile duct varices or 'pseudo-cholangiocarcinoma sign' in portal hypertension due to cavernous transformation of the portal vein显示文摘 | Bayraktar Y Balkanci F Kayhan B Ozenc A Arslan S Telatar H | 1992 | Am J Gastroenterol1992，87，12： | 1 |
| 11 | Is portal hypertension due to liver cirrhosis a major factor in the development of portal hypertensive gastropathy显示文摘 | Bayraktar Y Balkanci F Uzunalimoglu B | | 0，，03： | 1 |
| 12 | Congenital hepatic fibrosis associated with cavernous transformation of the protal vein显示文摘 | Bayraktar Y Balkanci F Kayhan B Uzunalimoglu B Ozenc A Ozdemir A | 1997 | Hepatogastroenterology1997，44，18： | 1 |
| 13 | Cavernous transformation of the portal vein is associated with pancreatic duct atrophy显示文摘 | Bayraktar Y Balkanci F Bayraktar M Koseoglu T Serap Arslan Uzunalimoglu B | 1996 | Hepatogastroenterology1996，43，10： | 1 |
| 14 | Is portal hypertension due to liver cirrhosis a magor faction in the development of portal hypertensive Gastropathy? 显示文摘 | Bayraktar Y Balkanci F Vzvnalimoglu B | 1996 | Am J Gastroenterol1996，91，7： | 1 |
| 15 | A comparison of chemoembolization with conventional chemotherapy and symptomatic treatment in cirrhotic patients with hepatocellular carcinoma显示文摘 | Bayraktar Y Balkanci F Kayhan B | 1996 | Hepatogastroenterology1996，43，9： | 1 |
| 16 | Bile duct varices or 'pseudo-cholangiocarcinoma sign' in portal hypertension due to cavernous transformation of the portal vein显示文摘 | BayraktarY Balkanci F Kayhan B | 1992 | Am J Gastroenterol1992，87，12： | 1 |
| 17 | Cavernous transformation of the portal vein is associated with pancreatic duct atrophy显示文摘 | Bayraktar Y Balkanci F Bayraktar M | 1996 | Hepatogastroenterology1996，43，10： | 1 |
| 18 | Bile duct varices or 'pseudo-cholangiocarcinoma sign' in portal hypertension due to cavernous transfomation of the portal vein显示文摘 | Bayraktar Y N Balkanci F Kaayhan B | 1992 | Am J Castroenterol1992，87，12： | 1 |
| 19 | Is congenital hepatic fibrosisa pure liver disease ? 显示文摘 | Ybnem 0 Ozkayar N Balkanci F | 2006 | Am J Gastroenterol2006，101，6： | 1 |
| 20 | Budd-Chiari syndrome: a common complication of Behcet's disease显示文摘 | Bayraktar Y Balkanci F Bayraktar M | 1997 | Am J Gastroenterol1997，92，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员